Every round, fund close and exit we can source, with the article it was reported in and what it actually said.
Gilmour Space and Hypersonix have signed a partnership to offer hypersonic flight testing, combining rocket launch and scramjet technology, announced at a National Reconstruction Fund event in Canberra to build sovereign capability.
OncoSil Medical has raised $5.6m from three large existing shareholders to fund overseas and domestic launches of its radiation therapy, after winning TGA and FDA clearances for pancreatic and bile duct cancer use.
Fintech investment in Australia rebounded in H1 2026 on large deals, including two crypto acquisitions, while the government unveiled a Financial Innovation Strategy and a new industry map counted 800 fintechs.
Neurizon Therapeutics, a Melbourne biotech developing an ALS treatment, has appointed industry veteran Dr Chris Bremer as CEO as its lead drug NUZ-001 heads toward Phase 2/3 trial results in 2027.
Arovella Therapeutics has produced its first clinical batch of ALA-101, a donor-derived cell therapy for blood cancer, and begun trials at a Melbourne hospital, with the first patient expected to be dosed this month.
Perth-listed robotics firm FBR announced a $4 million equity raise, mixing a share placement with a shareholder purchase plan, to finish testing its Mantis welder, roll out Hadrian bricklaying tech and repay debt.
Quarterly report from the Defender Global Fund flagging an 84.7% portfolio return, profits taken on SharonAI following its February Nasdaq uplisting, SharonAI's GPU collaboration with NVIDIA, and fresh investor subscriptions.
Defender's quarterly newsletter reports an exceptional quarter for its global fund, headlined by portfolio holding SharonAI, which surged after a February Nasdaq uplisting and an NVIDIA GPU deployment partnership.
Also Defender AM portfolio·Startup Daily·AFR Technology·Forbes Australia·Forbes Australia·Dealroom
Australian biotech ReNerve and RMIT received a government grant of nearly AUD500,000 for a joint project aiming to speed nerve repair after prostate operations, under a federal program.
Qantas and Airbus backed an unnamed Australian company's A$30 million raise to advance a Queensland plant that would make lower-carbon jet fuel.
NuEnergy Gas, an ASX-listed gas company, has secured commitments for a A$3.1 million private placement to fund early gas sales at Tanjung Enim in Indonesia and advance other contract areas.
OPTrust has tasked Lazard Australia with auctioning Flow Power, the Melbourne-founded green energy retailer it has majority-owned for eight years, with first bids due within a month.
Bumi's Australian unit has taken over ASX-listed Loyal Metals for A$79.1 million, with the shares to be delisted; separately, Indonet signed a $530.2 million loan for its subsidiary's data centre build.
Profiles space investor Will Scully-Power, whose Pine Gap firm backs Australian space startups and plans a larger US fund with partners; defence VC Beaten Zone has also wrapped up a $26 million fund.
Oleyn, an enterprise AI company, has secured backing from angel investors in Singapore and Australia, with banker Mamun Rashid among them, to support product development, hiring and overseas growth.
Street Talk reports EQT Partners has bid for Parratech, the Sydney brothers Jason and Stephen Fooks' data centre enclosure business, in a deal valuing it above $1 billion; other suitors remain.
Continental's board meets to choose a buyer for its Australian tyre and auto chain mycar, with Allegro Funds favoured; the German giant paid $350 million for the business eight years ago.
Payments group Zenith Payments has named Anthony Drury its new CEO. Kevin Butler moves from the top job into a Chief Payments Officer role, while James Swan became CFO in July.
Melbourne biotech ImmunoBiota courts investors for its still-open seed round around an oral Type 1 diabetes therapy; its recent Diabetes Australia award is recorded, while the flagged Series A and listing remain plans.
QIMR Berghofer's Ebivanta Therapeutics wins $1.5 million plus backing from biotech incubator Biointelect Venturer's first cohort to ready its mRNA vaccine against Epstein-Barr virus for clinical testing.
Investible announces the promotion of Nicholas Ooi to Investment Manager, describing his deal approach, portfolio work since 2023, and his path from law and consulting into venture capital.
Roundup of the week's Australia and New Zealand raises: Gridsight, Pearler and Apate.AI secure the biggest cheques, Drumbeat and GonGlobal add smaller sums, and ten AI startups join Airwallex's Latitude 37 program.
Australia's competition regulator approved Peter Warren Automotive's purchase of Wakeling Automotive's new car dealerships, on condition eight local dealership sites are divested to protect competition.
An analysis of what happens to brain-implant trial participants once studies end, covering Australia's growing neurotech sector, EpiMinder's FDA approval, Synchron's funding, and recommendations from a convened panel of specialists.
Queensland's government has granted Aviation Australia $3 million from its Sovereign Industry Development Fund to build a Townsville training centre with simulation equipment for future defence aviation maintenance engineers.
Intellivision Holdings of Singapore paid $2.6 million for a 17.71 percent voting stake in ASX-listed CurveBeam AI, disclosed through a filing with the Australian exchange.
Bain Capital, advised by Lazard banker Campbell Ray, is readying a bid for clinical trials provider Nucleus Network, which current owner Blackstone has listed for sale at a hoped $1 billion.
Ritchie Bros has been knocked out of the Pickles sale, leaving buyout houses such as EQT, Warburg Pincus and Pacific Equity Partners to work through the data room ahead of first bids.
Canva is pushing productivity tools like Docs and Sheets to win enterprise subscribers from Microsoft and Google, while slowing its AI rollout to control costs and trimming its revenue growth forecast.
Australian payment-fraud prevention company Eftsure has bought US vendor-data firm Relish, its third international expansion in about a year following backer Level Equity's earlier purchase of France's Sis ID; terms undisclosed.
Airwallex unveils Latitude 37, naming ten young Australian AI startups to its first cohort; members receive equity-free backing, mentorship, worldwide network access and overseas immersion trips.
Workforce platform Expert360 is being bought by AI hiring firm Swipejobs at a reported $16 million value, while its founder and earliest backers are set to receive nothing for their stakes.
Also Startup Daily
Women's health founders say weak local investment is pushing them offshore; Baymatob, Ovum and BreastScreen leaders describe funding struggles at a Sydney summit, with all-female teams receiving just 2% of 2025 startup capital.
Swyftx has made Andrea Yuen permanent CEO and Cathryn Lyall Chair. Yuen moved up from CFO and interim Co-CEO; Lyall, a Seed Space Venture Capital partner, steps up from interim Chair.
The critical minerals refiner has won government backing exceeding $1.98 million to advance its recovery process from laboratory scale to a pilot facility in Sydney.
FoodNavigator interview with Bramble Intelligence's Chris Mitchell on how AI shopping agents will reshape brand loyalty, category fortunes, and what food makers must do to stay visible to algorithms and shoppers.
Australian biotech ENA Respiratory, whose INNA-051 nasal spray targets respiratory viruses, has been granted $2.98 million via the Biointelect Venturer program to fund a trial in adults with asthma.
Brandon Capital is welcoming a $60 million commitment of public money via the NRF, earmarked for the firm's life-science investing.
HEO has released early imagery from its first close-range orbital inspection mission, with Continuum-1 imaging a rocket body alongside partners Satellogic and UNSW Canberra Space under Defence Trailblazer funding.
A Brisbane-founded ASX-listed operator is funding its biggest data centre build with a fresh share offer to existing holders, plus an expanded hybrid securities deal that drew more pension fund money.
Also Dealroom
Private equity firm CVC is taking a majority holding in Ambrose Construct Group, an insurance repair business founded in Queensland, through its sixth Asia Fund; the deal values the company near $700 million.
Truck parts group MaxiPARTS has drawn a conditional buyout approach from Ares and separately agreed to acquire a brake component supplier's assets for $11.2 million.
Brandon Capital has put roughly $60 million of National Reconstruction Fund money into ten biotech companies and warns R&D tax changes would hurt deep tech; portfolio company Myricx Bio went to Novartis.
Also australiatimes.com
Street Talk reports ASX-listed truck parts distributor MaxiPARTS has received a takeover approach from private equity firm Ares, which has appointed Macquarie Capital to advise on the potential deal.
Canberra is funding carbon management demonstrations: round two of a national program directs $32.6 million across seven projects, naming six recipients including Carbonaught, Australian Carbon Vault, Karbonix, MCi Carbon and Electralith.
South Australian soft plastics recycler Recycling Plastics Australia, recipient of a $20m federal grant, has entered voluntary administration with KPMG appointed, after a major supplier's collapse derailed its plan to fill REDcycle's gap.
Plant-based food maker OMG Group has locked in a $1.5 million placement, with beverage manufacturer Slades Beverages taking a cornerstone stake and becoming its oat milk production partner as sales grow.
ARENA marks 100 community batteries installed under its funding initiative and announces $23.2 million in new grants for three Round 2 battery projects led by YES Group, Ausgrid and the City of Newcastle.
Also Dealroom·RenewEconomy
A guide for founders on building AI-native iOS and Android apps, covering architecture choices, platform differences, pitfalls and upcoming Australian privacy rules, with examples from Hyper's portfolio.